Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations
This article reflects the views and opinions of the authors and should not be construed to represent the views and opinions of the U.S. government, the U.S. Food and Drug Administration, the National Institutes of Health, or any other public or private entity, who had no role in the writing of the report or the decision to submit the paper for publication.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Daniel B. Horton, Michael D. Blum, Mehmet Burcu Tags: Commentary Source Type: research
More News: Arthritis | Food and Drug Administration (FDA) | Funding | Government | Grants | Merck | National Institutes of Health (NIH) | Pediatrics | Rheumatology | Skin